Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Lab-Grown Lungs Survive Transplant into Mice

XTALKS VITALS NEWS

Lab-grown lungs could help researchers develop more effective therapeutics to treat lung cancer, among other lung diseases, by providing an accurate model with which to screen drug candidates.

Share this!

November 10, 2016 | by Sarah Hand, M.Sc.

Lab-grown mini lungs have successfully been transplanted into mice by researchers at the University of Michigan. Not only did the lung tissue survive the transplant process, but it also began to grow and differentiate in the immunosuppressed mice.

“In many ways, the transplanted mini lungs were indistinguishable from human adult tissue,” said Dr. Jason Spence, senior study author and associate professor in the Department of Internal Medicine and the Department of Cell and Developmental Biology at the University of Michigan Medical School. The findings – which were published in the journal, eLife – could offer researchers a new tool to study a variety of lung diseases.

Respiratory diseases such as lung cancer, are responsible for about one in every five deaths worldwide. Despite the many advances made in treating lung cancer over the past three decades, survival rates continue to be low.

Lab-grown lungs could help researchers develop more effective therapeutics to treat lung cancer, among other lung diseases, by providing an accurate model with which to screen drug candidates. In addition, this lab-grown tissue could be used to replace damaged lungs in patients with lung disease.



In order to grow the mini mice lungs ex vivo, the researchers manipulated a number of signaling pathways necessary for stem cell differentiation. Those signaling pathways were involved in a number of different areas of differentiation, including cell growth and organ formation.

In previous studies, the researchers were able to demonstrate that their lab-grown lungs contained all the necessary structures for proper organ functioning. The tissue contained bronchi, which are responsible for moving air both in, and out of the body, along with alveoli which facilitate gas exchange between the lungs and the bloodstream.

Unfortunately, the mini lungs weren’t organized in the same way endogenous lung cells are. To fix this, the researchers attempted to transplant the lab-grown tissue into mice, but were largely unsuccessful.

Using a biodegradable scaffold developed by researchers in the biomedical engineering department at the University of Michigan, the team were finally able to implant the mini lungs into the mice. The biodegradable scaffold provided the lung cells with the structure necessary for them to form a mature airway.

“In just eight weeks, the resulting transplanted tissue had impressive tube-shaped airway structures similar to the adult lung airways,” said Briana Dye, a graduate student in the University of Michigan Department of Cell and Developmental Biology. According to the researchers, the alveolar cells failed to grow in the transplant recipients, however many other specialized cell types were detected in the adult lab-grown lung.


Keywords: Lung Cancer, Organ Transplant, Tissue Scaffold


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Researchers Identify Role of ApoE4 Gene as Possible Drug Target in Alzheimer’s Disease

September 21, 2017 - A team of neurology researchers at Washington University School of Medicine in St. Louis have found that in the presence of the ApoE4 protein, another protein known as tau forms tangles in the brain which contributes to neuronal damage characteristic of Alzheimer’s disease.

Featured In: Life Science News


New Guidelines Address CAR-T Immunotherapy Toxicities to Prevent Patient Deaths

September 20, 2017 - Clinicians at The University of Texas MD Anderson Cancer Center have published new guidelines in the journal, Nature Reviews Clinical Oncology, which could help in the management of these toxicities.

Featured In: Biotech News, Drug Safety News


Microneedle Skin Patch Could Treat Common Metabolic Disorders

September 19, 2017 - Researchers at Columbia University Medical Center (CUMC) and the University of North Carolina have developed a microneedle skin patch impregnated with a drug capable of converting white fat into calorie-burning brown fat.

Featured In: Medical Device News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Five Reasons Why Toronto is Emerging as a Major Life Sciences Hub

REGISTER FOR THESE WEBINARS

Development and Manufacture of Highly Potent API Drug Products Throughout the Clinical Phases


Innovation through Integration – Providing Next Generation Biomedical Devices and Interconnects


Clinical Payments Case Studies: Improving Efficiency, Cash Management, and Compliance


Why Phase 3 Trials Fail: Oncology Case Studies and Lessons Learned


Copyright © 2016-2017 Honeycomb Worldwide Inc.